BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7564511)

  • 21. [Philadelphia chromosome-positive acute lymphoblastic leukemia showing normal karyotype at presentation].
    Maki K; Nakamura F; Gunji H; Arai Y; Mitani K
    Rinsho Ketsueki; 2003 Nov; 44(11):1110-2. PubMed ID: 14689877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular construction of Philadelphia chromosome and its relation to the clinical features].
    Kamada N; Tanaka K; Asou H
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1098-105. PubMed ID: 2053768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute lymphocytic leukemia with Philadelphia chromosome and rearrangements of bcr gene and deletion of 5' side and of TCR-delta gene].
    Ohnishi A; Kagiyama S; Shintate Y; Kimura N; Ohgami A; Takechi M; Tanaka K; Kamada N
    Rinsho Ketsueki; 1990 Jun; 31(6):820-6. PubMed ID: 2145450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS; Greene JM; McConnell TS; Willman CL
    Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary Philadelphia chromosome in a patient with acute lymphoblastic leukemia.
    Chen L; Stamatoullas A; Bastard C; Tilly H
    Cancer Genet Cytogenet; 2004 Jul; 152(2):132-5. PubMed ID: 15262432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction.
    Han JY; Theil KS
    Cancer Genet Cytogenet; 2006 Feb; 165(1):70-4. PubMed ID: 16490599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL p190 transgenic mice.
    Griffiths SD; Healy LE; Ford AM; Bennett CA; Voncken JW; Heisterkamp N; Groffen J; Greaves MF
    Oncogene; 1992 Jul; 7(7):1391-9. PubMed ID: 1377812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
    Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
    Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients.
    Janssen JW; Fonatsch C; Ludwig WD; Rieder H; Maurer J; Bartram CR
    Leukemia; 1992 May; 6(5):463-4. PubMed ID: 1593911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-appearing Philadelphia chromosome in a patient with acute nonlymphocytic leukaemia derived from myelodysplastic syndrome: detection of P210- and P190-type bcr/abl fusion gene transcripts at the leukaemic stage.
    Katsuno M; Yamashita S; Sadamura S; Umemura T; Hirata J; Nishimura J; Nawata H
    Br J Haematol; 1994 May; 87(1):51-6. PubMed ID: 7524618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
    Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A granulocytic population with rearranged immunogenotype in chronic myelocytic leukemia blast crisis and Philadelphia-chromosome-positive acute leukemia with cross-lineage nature.
    Kita K; Shimizu N; Miwa H; Ikeda T; Nishii K; Morita N; Uchida T; Shirakawa S; Tsutani H; Nasu K
    Leukemia; 1993 Feb; 7(2):251-7. PubMed ID: 8381195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCR/ABL rearrangement with b3a3 fusion transcript in a case of childhood acute lymphoblastic leukemia.
    Kim J; Park TS; Lyu CJ; Song J; Lee KA; Kim SJ; Lee HJ; Choi JR
    Cancer Genet Cytogenet; 2009 Mar; 189(2):132-7. PubMed ID: 19215796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.
    Radich J; Gehly G; Lee A; Avery R; Bryant E; Edmands S; Gooley T; Kessler P; Kirk J; Ladne P; Thomas ED; Appelbaum FR
    Blood; 1997 Apr; 89(7):2602-9. PubMed ID: 9116308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.
    van Rhee F; Marks DI; Lin F; Szydlo RM; Hochhaus A; Treleaven J; Delord C; Cross NC; Goldman JM
    Leukemia; 1995 Feb; 9(2):329-35. PubMed ID: 7869772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular diagnosis of the Philadelphia chromosome in chronic myelogenous and acute lymphoblastic leukemias by PCR.
    Maurer J; Kinzel H; Nentwig T; Thiel E
    Dis Markers; 1990; 8(4):211-8. PubMed ID: 2088636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Undifferentiated immunophenotypes and not expression of BCR-ABL can be associated in adult Mestizo Mexican patients with ALL.
    Vázquez-Franco JE; Reyes-Maldonado E; Montiel-Cervantes LA; Lezama RA
    Rev Invest Clin; 2012; 64(1):32-9. PubMed ID: 22690527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
    Pfeifer H; Lange T; Wystub S; Wassmann B; Maier J; Binckebanck A; Giagounidis A; Stelljes M; Schmalzing M; Dührsen U; Wunderle L; Serve H; Brück P; Schmidt A; Hoelzer D; Ottmann OG
    Leukemia; 2012 Jul; 26(7):1475-81. PubMed ID: 22230800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.